Sfoglia per Autore "Argentou, N."
Items 1-6 di 6
-
Foxp3 Expression in Liver Correlates with the Degree but Not the Cause of Inflammation
Speletas, M.; Argentou, N.; Germanidis, G.; Vasiliadis, T.; Mantzoukis, K.; Patsiaoura, K.; Nikolaidis, P.; Karanikas, V.; Ritis, K.; Germenis, A. E. (2011)Patients with chronic viral hepatitis display increased expression of Foxp3 in liver, suggesting that Tregs expansion contributes to persistent infection. The purpose of this study was to elucidate whether the expression ... -
Liver FOXP3 and PD1/PDL1 expression is down-regulated in chronic HBV hepatitis on maintained remission related to the degree of inflammation
Germanidis, G.; Argentou, N.; Hytiroglou, P.; Vassiliadis, T.; Patsiaoura, K.; Germenis, A. E.; Speletas, M. (2013)Background and Aim: T cell expression of PD1 and inhibition of T effector cells by Foxp3(+)-T regulatory cells are among the most powerful mechanisms for achieving a balanced immune response. Our aim was to investigate, ... -
LIVER PD-1/PDL-1/PD-L2 MRNA EXPRESSION QUANTITATIVE ANALYSIS IN PATIENTS WITH CHRONIC HBV AND HCV HEPATITIS
Argentou, N.; Germanidis, G.; Vassiliadis, T.; Patsiaura, K.; Mantzoukis, K.; Ritis, K.; Eleftheriadis, D.; Evgenidis, N.; Nikolaidis, P.; Germenis, A. E.; Speletas, M. (2010) -
Overexpression of SMAD7 protects liver from TGFb/Smad-mediated fibrogenesis
Argentou, N.; Germanidis, G.; Apostolou, E.; Vasiliadis, T.; Sideras, P.; Germenis, A. E.; Speletas, M. (2012) -
Rapid detection of MYD88-L265P mutation by PCR-RFLP in B-cell lymphoproliferative disorders
Argentou, N.; Vassilopoulos, G.; Ioannou, M.; Germenis, A. E.; Speletas, M. (2014) -
Survivin isoform expression patterns in CML patients correlate with resistance to imatinib and progression, but do not trigger cytolytic responses
Speletas, M.; Argentou, N.; Karanikas, V.; Gramoustianou, E. S.; Mandala, E.; Braimi, M.; Matsouka, P.; Ritis, K.; Germenis, A. E. (2011)Tyrosine-kinase inhibitors are very effective in patients with CML, but in most cases the disease relapses after their discontinuation. As a result, novel approaches should be considered, such as anti-survivin treatment ...